Full-Time
Associate
Clover Health
501-1,000 employees
Medicare Advantage insurer with personalized care
No salary listed
New York, NY, USA
In Person
 AI & Machine Learning (2) |
|---|
| , |
- You have taught yourself a new language, reverse-engineered an API, and talked your way into a room.
- Solve real problems in healthcare - an industry that's fundamentally broken.
- Build with artificial intelligence from the ground up.
- Ship code that impacts millions.
- Get big things done.
- You will work in person, in New York City.
- You will ship real systems, not proofs of concept.
- You will deal with messy data, edge cases, and lives at stake.
Clover Health provides Medicare Advantage plans for seniors in the United States, offering coverage that goes beyond traditional Medicare. Its services include personalized care, fitness memberships, home checkups, drug coverage, and Medigap insurance, with revenue coming from member premiums and Medicare reimbursements. The product works by enrolling members in Medicare Advantage and delivering added benefits through a network of healthcare providers and fitness centers, plus home visits and proactive support to manage health. The company differentiates itself with a focus on tailored, attentive care and a growing provider network to enhance member benefits, aiming to improve health outcomes. Its primary goal is to help seniors stay healthier and reduce out-of-pocket costs by combining comprehensive coverage with personalized services.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Nashville, Tennessee
Founded
2014
Simplify's Take
What believers are saying
- Q1 2026 revenue reached $749.2 million, up 62% year over year.
- Adjusted EBITDA hit $40.26 million, and full-year guidance rose to $60 million midpoint.
- The April 7, 2026 HealthEx launch deepens member engagement through secure data access.
What critics are saying
- UnitedHealthcare, Humana, and CVS/Aetna can outspend Clover on richer benefits.
- CMS Star Ratings pressure rebate dollars and enrollment growth if quality slips.
- Low cash reserves and recent burn keep equity dilution risk elevated in 2026.
What makes Clover Health unique
- Clover Health pairs Medicare Advantage coverage with Clover Assistant clinical decision software.
- Nearly all plans are PPOs, offering wider provider choice than HMO rivals.
- Counterpart Health extends Clover's interoperability stack beyond members to other health plans.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Clover Health who can refer or advise you
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Performance Bonus
Unlimited Paid Time Off
Remote Work Options
Parental Leave
Professional Development Budget
Phone/Internet Stipend
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↑ 0%2 year growth
↓ -2%Clover Health reported fourth-quarter revenues of $487.7 million, up 44.7% year on year and exceeding analysts' expectations by 4.4%. The Medicare Advantage provider delivered the strongest performance among 12 tracked health insurance providers, posting the biggest analyst beat and fastest revenue growth in the group. The company added 4,577 customers during the quarter, bringing its total to 113,803. Clover uses proprietary software called Clover Assistant to help physicians manage patient care for seniors. Despite the strong results, shares fell 5.3% following the announcement and currently trade at $2.04, suggesting investor expectations may have been higher than Wall Street's published projections. CEO Andrew Toy said the results validated the company's business model despite headwinds during the year.
Clover Health has partnered with HealthEx to enable Medicare Advantage members to securely access and share their clinical records and claims data. Built on Counterpart Health infrastructure, the collaboration allows members to connect health information to digital tools like Claude for better care navigation. The partnership addresses healthcare data fragmentation by letting members verify their identity, authorise access and retrieve records through a single streamlined experience, eliminating multiple portal logins. Members can share data with providers, health applications and AI platforms, with each entity governed by its own privacy policy. Counterpart Health powers the underlying interoperability infrastructure, creating a scalable foundation for other health plans. The capability extends Clover's recent interoperability work with Kno2 and supports federal interoperability efforts promoting patient data access rights.
Clover Health shares have fallen 42.4% over six months to $1.86, prompting concerns about the company's viability. With just $1.92 billion in trailing 12-month revenue, the health insurer struggles with scale disadvantages in an industry where size matters for operational efficiency and customer trust. The company's financial position remains precarious. Clover Health has posted an average free cash flow margin of negative 6.8% over five years, burning $68.98 million in cash last year. With $120.3 million in cash and no debt, it has approximately 21 months of runway remaining. Analysts warn shareholders face potential dilution if the company must raise capital to continue operations, making it a stock to avoid until it demonstrates consistent free cash flow generation.
Clover Health Investments has achieved full-year adjusted EBITDA profitability in 2025 and guided to its first year of GAAP net income profitability in 2026, with projected net income of $0–20 million and revenue of $2.81–2.92 billion. The Medicare Advantage insurer grew membership 38% year-over-year to approximately 114,000 members, driven by its risk-bearing model and Clover Assistant platform. Management reported underlying medical cost trends remained well controlled at around 5% annually, excluding pharmacy costs. CEO Andrew Toy said Clover sustained profitability whilst rapidly expanding membership through a model retaining full underwriting risk. The company introduced consolidated gross profit as its primary operating metric, reaching $356 million in 2025 with guidance of $470–510 million for 2026. Clover ended the quarter with $320 million in cash.
Clover Health has achieved full-year adjusted EBITDA profitability in 2025 whilst delivering 38% membership growth and controlled medical cost trends, despite elevated industry-wide utilisation. CEO Andrew Toy noted the company absorbed first-year dilution from Medicare Advantage membership growth whilst retaining full underwriting risk. The company expects to achieve its first full year of GAAP net income and earnings per share profitability in 2026. Toy emphasised that regulatory pressures weakening competitors have strengthened Clover's positioning, as incumbents reduced benefits and exited markets. Since 2021, Clover has focused on clinical value rather than coding intensity, a strategy now proving advantageous as the broader Medicare Advantage market faces challenges. The company believes its cohort economics are amongst the strongest in the industry.